John Alam

Works at

Eip Pharma
Ceo

Sources: reporter.nih.gov

Grants and prizes

National Institute on Aging
R01, A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB), R01AG080536, 2023–2026, 11 Mar 2025

Sources: reporter.nih.gov